Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

New market introduction for valsartan

Nov. 26, 1996

Cozaar introduced in U.K.

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Spanish investigators discover novel antihypertensive agent

Nov. 21, 1996

Chiesi reports pharmacological profile of CHF-2363

Nov. 21, 1996

Merck & Co. launches Hyzaar in France

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...